Ethereum crashed in Q1. Could May’s Pectra upgrade bring it back?

JOINN Biologics

company

About

Your premier CDMO for biologics drug development and manufacturing, from early development, to IND, to commercial stage.

  • 251 - 500

Details

Last Funding Type
Series A
Last Funding Money Raised
$60M
Industries
Biopharma,Biotechnology,Manufacturing
Founded date
May 1, 2018
Number Of Employee
251 - 500
Operating Status
Active

JOINN Biologics is a California Bay Area-based company that is committed to the advancement of biotech and biopharmaceutics through our premier contract manufacturing and development services for biologics and advanced therapies. A vital part of the JOINN Family's successful 20+ year track record of supporting drug discovery and development, we provide a complete range of CDMO services, from early development to clinical manufacturing, for our clients and partners on a global scale.


Core Capabilities

• Molecular/developability assessment

• cGMP clinical trial materials production

• Commercial-scale cGMP manufacturing

• Non-GMP protein expression and purification

• Cell line development

• Upstream process development

• Downstream purification development

• Analytical and formulation development

• Documentation and reporting to support regulatory filings


Mission

It is our mission to provide our global clients and partners with a complete range of premier contract development and manufacturing services for biologics and advanced therapies, from early custom development to clinical manufacturing, to further accelerate the development of high-quality biologics, meeting patients' needs and delivering long-lasting value to the biotech and biopharmaceutical industry.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$60M
JOINN Biologics has raised a total of $60M in funding over 2 rounds. Their latest funding was raised on Dec 10, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 10, 2019 Series A $60M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
JOINN Biologics is funded by 2 investors. Chaosheng Capital and Suzhou Xiangtang Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Chaosheng Capital Series A
Suzhou Xiangtang Venture Capital Series A